The vascular embolization plugs and coils market in Japan is expected to grow at a compound annual growth rate (CAGR) of 3% through 2030, driven by growing preference for endovascular minimally invasive procedures over traditional surgeries, forecasts GlobalData, a leading data, and analytics company.

GlobalData’s latest report, “Vascular Embolization Plugs and Coils (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)”, reveals that Terumo Corp and Boston Scientific Corp are the leading players in Japan, together accounting for more than 45% of the overall vascular embolization plugs and coils market in 2021.

Tanisha Verma, Senior Medical Devices Analyst at GlobalData, comments: “Embolization coils are preferred over embolization plugs in treating patients with peripheral aneurysms, type II endoleaks and gastrointestinal bleeding due to factors such as low cost, ease of deployment, availability of variety of options in terms of diameter and length of the coil and better patient outcomes.”

Detachable coils account for more than 80% of the vascular embolization plugs and coils market in Japan in 2021. The average number of embolization coils used per procedure varies depending on the factors such as size of the aneurysm, length of the coil and skill set of healthcare professional.

Verma concludes: “Vascular embolization plugs and coils have gained popularity over time not just because of their efficiency in treating aneurysms but also due to the advancements offered in this field. However, factors such as high cost of embolization plugs, lack of required number of trained specialists available, limited access to diagnostic facilities to rural population and post-procedural complications such as thrombosis and occlusion of non-target vessel should be addressed to further drive the market.”